title: Increased serotonin release across the coronary bed during a nonischemic interval in patients with vasospastic angina.
abstract: BACKGROUND
  Platelet activation and coagulation abnormality have been observed during coronary spasm. It is crucial whether platelet activation occurs even during a nonischemic period.
  
  
  OBJECTIVE
  This study was designed to determine whether platelets might be activated across the coronary bed during a nonischemic interval in patients with vasospastic angina.
  
  
  METHODS
  Plasma levels of serotonin, 6-keto-prostaglandin F1 alpha, and catecholamines in the aorta and the coronary sinus were simultaneously measured in 16 patients with vasospastic angina and 13 control patients with nonischemic heart disease.
  
  
  RESULTS
  None of these patients showed myocardial ischemia during sampling. The difference in transcardiac plasma levels of serotonin in patients with vasospastic angina was significantly higher than that in controls (1.48 +/- 1.08 ng/ml vs. 0.07 +/- 0.12 ng/ml, respectively, p < 0.001). Coronary sinus plasma norepinephrine levels in these two groups were almost the same (204.8 +/- 110.8 pg/ml vs. 190.4 +/- 131.6 pg/ml, respectively). The ratio of 6-keto-prostaglandin F1 alpha in the coronary sinus and the aorta was not different between the two groups (1.17 +/- 0.96 in patients with vasospastic angina vs. 1.15 +/- 0.68 in controls).
  
  
  CONCLUSIONS
  These data suggest that platelet activation across the coronary bed should be ascribed to endothelial dysfunction. Lack of compensatory enhancement of prostacyclin production might be concerned with dysfunction of coronary endothelial cells in these patients.
authors.affiliation: Fourth Department of Internal Medicine, Shimane Medical University, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Murakami
authors.forename: Y
authors.initials: Y
authors.lastname: Ishinaga
authors.forename: K
authors.initials: K
authors.lastname: Sano
authors.forename: R
authors.initials: R
authors.lastname: Murakami
authors.forename: Y
authors.initials: Y
authors.lastname: Kinoshita
authors.forename: J
authors.initials: J
authors.lastname: Kitamura
authors.forename: K
authors.initials: K
authors.lastname: Kobayashi
authors.forename: S
authors.initials: S
authors.lastname: Okada
authors.forename: K
authors.initials: K
authors.lastname: Matsubara
authors.forename: T
authors.initials: T
authors.lastname: Shimada
authors.forename: S
authors.initials: S
authors.lastname: Morioka
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000787:Angina Pectoris / Q000097:blood* / Q000503:physiopathology; D001011:Aorta; D006328:Cardiac Catheterization; D002395:Catecholamines / Q000097:blood; D002851:Chromatography, High Pressure Liquid; D003329:Coronary Vasospasm / Q000097:blood* / Q000503:physiopathology; D003331:Coronary Vessels; D015716:Electrocardiography, Ambulatory; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D015539:Platelet Activation / Q000502:physiology*; D011863:Radioimmunoassay; D012307:Risk Factors; D012701:Serotonin / Q000097:blood*
chemical_list: D002395:Catecholamines; D012701:Serotonin; D015121:6-Ketoprostaglandin F1 alpha